A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.


Updates from The Motley Fool

Latest updates on Cepheid from Fool.com.
Why Cepheid Stock Nosedived

Molecular diagnostic company Cepheid may need to do some internal analyzing after its full-year o...



Stock Performance

View Interactive CPHD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cepheid.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($0.51)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John L. Bishop, CEO

46% Approve

Based on 41 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cepheid.

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

  • Exchange: NASDAQ
  • Sector: Technology
  • Industry: Electronics